SCHEMBL742901

SCHEMBL742901

Cn1ccc(C(=O)Nc2n[nH]c3sc(C(=O)NC(C)(C)c4ccccc4)cc23)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 2/20 0.49
BCR P11274 2/20 0.49
AURKA O14965 1/20 0.47
EGLN1 Q9GZT9 1/20 0.42
ROCK1 Q13464 1/20 0.41
RAB9A P51151 7/20 0.37
NPC1 O15118 6/20 0.37
SMN1; SMN2 Q16637 4/20 0.37
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
TP53 P04637 1/20 0.37
PKM P14618 1/20 0.36
NFKB1 P19838 2/20 0.36
NFKB2 Q00653 2/20 0.36
RELA Q04206 2/20 0.36
HPGD P15428 1/20 0.36
NPSR1 Q6W5P4 1/20 0.35
NTRK1 P04629 1/20 0.35
LMNA P02545 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1779413 0.94 ABL1 (0.45) ABL1BCRAURKAEGLN1ROCK1
SCHEMBL742071 0.85 AURKA (0.46) ABL1BCRAURKAEGLN1RAB9A
SCHEMBL740292 0.85 AURKA (0.55) ABL1BCRAURKARAB9ANPC1
SCHEMBL4631874 0.84 ROCK1 (0.43) ROCK1RAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL739086 0.84 AURKA (0.50) ABL1BCRAURKAEGLN1RAB9A
SCHEMBL742025 0.84 AURKA (0.53) ABL1BCRAURKAEGLN1ROCK1
SCHEMBL741093 0.82 AURKA (0.46) ABL1BCRAURKAROCK1RAB9A
SCHEMBL741311 0.82 AURKA (0.53) ABL1BCRAURKARAB9ANPC1
SCHEMBL739900 0.82 AURKA (0.47) ABL1BCRAURKAEGLN1RAB9A
SCHEMBL743308 0.81 AURKA (0.48) ABL1BCRAURKARAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed